Vista Pharmaceuticals Ltd. BSE: 524711

Download real time

9.40 -0.10 (-1.05%)

Near 52W Low of ₹9.10

5,595

BSE Volume

BSE 22 Sep, 2025 9:49 AM (IST)

Vista Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vista Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Vista Pharmaceuticals Ltd.

09 Sep 2025

9.40

-1.05%

Company Update

Vista Pharmaceuticals Ltd - 524711 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation - Newspaper publication of Notice of 34th Annual General Meeting of the company for Financial Year 2024-25

Vista Pharmaceuticals Ltd.

08 Sep 2025

9.40

-1.05%

AGM

Vista Pharmaceuticals Ltd - 524711 - Intimation Of Book Closure Regarding 34" Annual General Meeting

BSE India

Intimation of Book Closure regrading 34th Annual General Meeting of the company

Vista Pharmaceuticals Ltd.

08 Sep 2025

9.40

-1.05%

Corp. Note

Vista Pharmaceuticals Ltd - 524711 - Reg. 34 (1) Annual Report.

BSE India

Submission of Annual Report for the FY 2024-25

Vista Pharmaceuticals Ltd.

08 Sep 2025

9.40

-1.05%

AGM

Vista Pharmaceuticals Ltd - 524711 - 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, …

BSE India

Notice of 34th Annual General Meeting of Vista Pharmaceuticals Limited to be held on Tuesday 30th September 2025

Vista Pharmaceuticals Ltd.

13 Aug 2025

9.40

-1.05%

Company Update

Vista Pharmaceuticals Ltd - 524711 - Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing …

BSE India

Re appointment of Mr. Murali Meraga (DIN:05237507) as an Managing Director of the company

Vista Pharmaceuticals Ltd.

13 Aug 2025

9.40

-1.05%

Company Update

Vista Pharmaceuticals Ltd - 524711 - Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An …

BSE India

Re Appointment of Mr. Pavan Sathvik Gilaka (DIN: 09733182) as An Whole time Director of the company

Vista Pharmaceuticals Ltd.

13 Aug 2025

9.40

-1.05%

Company Update

Vista Pharmaceuticals Ltd - 524711 - Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole …

BSE India

Re-appointment of Mr. Dhananjaya Alli (DIN: 00610909) as an Whole Time Director of company

Vista Pharmaceuticals Ltd.

13 Aug 2025

9.40

-1.05%

Board Meeting

Vista Pharmaceuticals Ltd - 524711 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited …

BSE India

Outcome of the Board Meeting - Unaudited Financial results for quarter ended 30.06.2025

Vista Pharmaceuticals Ltd.

13 Aug 2025

9.40

-1.05%

Result

Vista Pharmaceuticals Ltd - 524711 - Results - Unaudited Financial Results For The Quarter Ended 30.06.2025

BSE India

Unaudited Financial results for the quarter ended 30.06.2025

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1.52	3.47	1.87	-56.2%	-18.7%
Operating Profit Qtr	-1.11	-0.91	-0.78	-22.0%	-42.3%
Net Profit Qtr	-1.29	-1.50	-0.86	14.0%	-50.0%
Earning Per Share Adjusted latest Qtr	-0.21	-0.24	-0.14	12.5%	-50.0%

* Standalone data

Detailed Results

Vista Pharmaceuticals Ltd.

06 Aug 2025

9.40

-1.05%

Board Meeting

Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for Approval Of Unaudited Financial Results For …

BSE India

Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve 1. Unaudited Financial Results for the quarter ended 30.06.2025 2. Limited Review Report for the quarter ended 30.06.2025 3. Any other business with the permission of the chair.

Is Vista Pharmaceuticals Ltd. worth buying?

18 Votes:

Buy 66.67%

Sell 16.67%

Hold 16.67%